The U.S. Food & Drug Administration (FDA) released a new proposed draft guidance in February that would change the FDA’s outlook on the engagement of a data monitoring committee (DMC) in clinical trials.
Originally...more
The rule allowing for providers to prescribe controlled substances via telehealth, set to expire for new patient-provider relationships on November 11, has been extended through the end of 2024....more
11/10/2023
/ Controlled Substances ,
Coronavirus/COVID-19 ,
DEA ,
Department of Health and Human Services (HHS) ,
Electronic Prescribing ,
Extensions ,
Health Care Providers ,
Healthcare ,
Life Sciences ,
Patient Access ,
Prescription Drugs ,
Public Health Emergency ,
Telehealth ,
Telemedicine